Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc A Pfeffer

Showing results (121-130 of 520) with videos related to

Pageof 52
Sort By:
The American Journal of Medicine|February 15, 2003
Value of the electrocardiogram in predicting left ventricular enlargement and dysfunction after myocardial infarctionCostantina Manes, Marc A Pfeffer, John D Rutherford, et al.
JACC. Heart Failure|November 3, 2022
Steroidal MRA Across the Spectrum of Renal Function: A Pooled Analysis of RCTsJoão Pedro Ferreira, Bertram Pitt, John J V McMurray, et al.
European Journal of Heart Failure|March 3, 2020
Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failurePooja Dewan, Alice Jackson, Carolyn S P Lam, et al.
The American Journal of Cardiology|April 22, 2011
Opposing effects of β blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery diseaseOrly Vardeny, Hajime Uno, Eugene Braunwald, et al.
European Journal of Internal Medicine|October 30, 2023
Long-term cardiovascular events, graft failure, and mortality in kidney transplant recipientsCharlotte Andersson, Ditte Hansen, Søren Schwartz Sørensen, et al.
Lancet (London, England)|September 19, 2003
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trialJohn J V McMurray, Jan Ostergren, Karl Swedberg, et al.
Circulation|December 10, 2019
Current Smoking Is Associated With Lower Concentrations of High-Sensitivity Cardiac Troponin T in Patients With Stable Coronary Artery Disease: The PEACE TrialJulia B Skranes, Brian L Claggett, Peder L Myhre, et al.
Lancet (London, England)|September 19, 2003
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved TrialSalim Yusuf, Marc A Pfeffer, Karl Swedberg, et al.
Circulation|August 25, 2010
Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapyScott D Solomon, Elyse Foster, Mikhail Bourgoun, et al.
Lancet (London, England)|September 19, 2003
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trialChristopher B Granger, John J V McMurray, Salim Yusuf, et al.
Pageof 52

Showing results (121-130 of 520) with videos related to

Sort By:
Pageof 52
The American Journal of Medicine|February 15, 2003
Value of the electrocardiogram in predicting left ventricular enlargement and dysfunction after myocardial infarctionCostantina Manes, Marc A Pfeffer, John D Rutherford, et al.
JACC. Heart Failure|November 3, 2022
Steroidal MRA Across the Spectrum of Renal Function: A Pooled Analysis of RCTsJoão Pedro Ferreira, Bertram Pitt, John J V McMurray, et al.
European Journal of Heart Failure|March 3, 2020
Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failurePooja Dewan, Alice Jackson, Carolyn S P Lam, et al.
The American Journal of Cardiology|April 22, 2011
Opposing effects of β blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery diseaseOrly Vardeny, Hajime Uno, Eugene Braunwald, et al.
European Journal of Internal Medicine|October 30, 2023
Long-term cardiovascular events, graft failure, and mortality in kidney transplant recipientsCharlotte Andersson, Ditte Hansen, Søren Schwartz Sørensen, et al.
Lancet (London, England)|September 19, 2003
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trialJohn J V McMurray, Jan Ostergren, Karl Swedberg, et al.
Circulation|December 10, 2019
Current Smoking Is Associated With Lower Concentrations of High-Sensitivity Cardiac Troponin T in Patients With Stable Coronary Artery Disease: The PEACE TrialJulia B Skranes, Brian L Claggett, Peder L Myhre, et al.
Lancet (London, England)|September 19, 2003
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved TrialSalim Yusuf, Marc A Pfeffer, Karl Swedberg, et al.
Circulation|August 25, 2010
Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapyScott D Solomon, Elyse Foster, Mikhail Bourgoun, et al.
Lancet (London, England)|September 19, 2003
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trialChristopher B Granger, John J V McMurray, Salim Yusuf, et al.
Pageof 52